• Company
• JW Pharmaceutical’s new drugs enter clinical trials
• by Son, Hyung-Min Jun 21, 2024 05:46am

• Opinion
• [Reporter’s View] Reliability Verification Review Committee
• by Lee, Hye-Kyung Jun 20, 2024 05:48am

• Company
• ‘Treatment access improved for Lysosomal Storage Diseases'
• by Son, Hyung-Min Jun 20, 2024 05:48am

• Policy
• When will 'Paxlovid' become reimbursable?
• by Lee, Tak-Sun Jun 20, 2024 05:48am

• Company
• ‘Long-term treatment for osteoporosis is now possible'
• by Son, Hyung-Min Jun 20, 2024 05:48am

• Policy
• 'Approvals-Reimbursement Reviews-Price Negotiations' pilot
• by Lee, Hye-Kyung Jun 20, 2024 05:48am

• Company
• HK inno.N and others license out jointly developed candidate
• by Kim, Jin-Gu Jun 20, 2024 05:48am

• Company
• K-pharma speeds up Keytruda biosimilar development...
• by Kim, Jin-Gu Jun 19, 2024 05:46am

• Company
• Suhee Shin appointed new General Manager of Amgen Korea
• by Eo, Yun-Ho Jun 19, 2024 05:46am

• Company
• New multiple sclerosis drug Ocrevus is approved in Korea
• by Son, Hyung-Min Jun 19, 2024 05:46am